Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 17/20 | 0.71 |
| ▸ | TDO2 | P48775 | 17/20 | 0.71 |
| ▸ | IDO2 | Q6ZQW0 | 12/20 | 0.71 |
| ▸ | APAF1 | O14727 | 2/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | NPC1 | O15118 | 1/20 | 0.71 |
| ▸ | MITF | O75030 | 1/20 | 0.71 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.71 |
| ▸ | RAB9A | P51151 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4585634 | 0.91 | IDO1 (0.80) | IDO1TDO2IDO2APAF1MEN1 | |
| SCHEMBL17830818 | 0.90 | IDO1 (0.83) | IDO1TDO2IDO2APAF1MEN1 | |
| SCHEMBL26614214 | 0.86 | IDO1 (0.73) | IDO1TDO2IDO2APAF1MEN1 | |
| SCHEMBL30639074 | 0.85 | IDO1 (0.71) | IDO1TDO2IDO2APAF1MEN1 | |
| SCHEMBL26614220 | 0.85 | IDO1 (0.71) | IDO1TDO2IDO2APAF1MEN1 | |
| SCHEMBL9103254 | 0.83 | IDO1 (0.80) | IDO1TDO2IDO2APAF1MEN1 | |
| SCHEMBL31680506 | 0.83 | TDO2 (1.00) | IDO1TDO2IDO2APAF1MEN1 | |
| SCHEMBL9115231 | 0.83 | TDO2 (1.00) | IDO1TDO2IDO2APAF1MEN1 | |
| SCHEMBL9105370 | 0.83 | IDO1 (1.00) | IDO1TDO2IDO2APAF1MEN1 | |
| SCHEMBL4586093 | 0.82 | APAF1 (0.71) | IDO1TDO2IDO2APAF1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9630969-B2 | N-alkyl tryptanthrin derivative, preparation method for same, and application thereof | SHANGHAI TIN TSZ BIO VALLEY BIOLOGICAL ENGINEERING CO., LTD (CN) | 2017-04-25 | — | — | US | disclosed |
| US-9630969-B2 | N-alkyl tryptanthrin derivative, preparation method for same, and application thereof | SHANGHAI TIN TSZ BIO VALLEY BIOLOGICAL ENGINEERING CO., LTD (CN) | 2017-04-25 | — | — | US | disclosed |
| US-20160168152-A1 | N-ALKYL TRYPTANTHRIN DERIVATIVE, PREPARATION METHOD FOR SAME, AND APPLICATION THEREOF | SHANGHAI TIN TSZ BIO VALLEY BIOLOGICAL ENGINEERING CO., LTD (CN) | 2016-06-16 | — | — | US | disclosed |
| US-20160168152-A1 | N-ALKYL TRYPTANTHRIN DERIVATIVE, PREPARATION METHOD FOR SAME, AND APPLICATION THEREOF | SHANGHAI TIN TSZ BIO VALLEY BIOLOGICAL ENGINEERING CO., LTD (CN) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168152-A1 | N-ALKYL TRYPTANTHRIN DERIVATIVE, PREPARATION METHOD FOR SAME, AND APPLICATION THEREOF | IDO1, IDO2, TPH1 | IDO1 1/4885TDO2 9/4885IDO2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.